Scientists test 'Teaching' immune cells to stop attacking the brain in MS
NCT ID NCT07020715
Summary
This early-stage trial is testing a personalized cell therapy designed to slow the progression of disability in people with progressive forms of multiple sclerosis (MS). Doctors will take a participant's own immune cells, modify them in a lab to potentially calm the immune attack on the brain and spinal cord, and then reinfuse them. The study will follow 14 participants to see if the treatment is safe and if it can help stabilize or improve their level of disability.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Germans Trias i Pujol Hospital (HUGTiP)
Badalona, 08916, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
Universitair Ziekenhuis Antwerpen (UZA)
Edegem, 2650, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.